CureMetrix

curemetrix.com · San Diego, United States of America

CureMetrix is a medical imaging AI company that develops FDA-cleared software to assist radiologists in interpreting screening mammograms, improving cancer detection and workflow efficiency. Its cloud-based and on-premise solutions use deep learning to analyze breast images, flag suspicious regions, and provide quantitative scores that support clinical decision-making for hospitals, imaging centers, and health systems. The company generates revenue through software licensing and usage-based subscriptions to healthcare providers and partners.

Revenue
<$10M
Employees
1 - 50
Founded
2014
Headquarters
San Diego, United States of America

CureMetrix customers on Arbolus

Total customers 8 8 current · 0 former
Reviews growth 6 new reviews since May 2026

Customers who reviewed CureMetrix

Seniority of CureMetrix customers

The largest group of people who reviewed CureMetrix holds C-Suite roles (43%), followed by Manager (29%) and Director (29%).

  • C-Suite 43%
  • Manager 29%
  • Director 29%

Customers sample

Operations Generalist C-Suite NPS 9
Other Partner Manager NPS 9 Will renew
Data Analyst Not specified NPS 8

Employer names and spend open once the report publishes.

What 8 Arbolus experts think of CureMetrix

Overall sentiment: Positive

NPS scores are skewed toward the positive, with 25% of experts giving a perfect 10 and most scores clustering at 8-10. Renewal intent demonstrates a split: those with longer implementation (>1 year) and higher spends typically indicate positive renewal, while pilot-stage and mid-spend customers are not sure or negative. Stickiness is high among long-term users, especially in pharmaceutical R&D. Key sentiment drivers include perceived reliability, sustained rollout, and measurable benefits in operational environments.

Tell us when the CureMetrix report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

37 Net Promoter Score, from 8 scored reviews
  • Promoters 4
  • Passives 3
  • Detractors 1

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 60%
  • Will renew 3
  • Undecided 2
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 100% 1 answer
  • Director 50% 2 answers
  • Manager 50% 2 answers
  • 8.7/10 Average score from customers who will renew
  • 6.5/10 Average score from undecided customers

Top alternatives

Most weighed by CureMetrix customers

For people who use CureMetrix

Do you use CureMetrix at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 8 customers of CureMetrix have already contributed

Takes a few minutes. Your identity stays anonymous.